Nonhuman primate infants have an impaired respiratory but not systemic IgG antibody response following influenza virus infection

Virology

Volumn 476, Issue , 2015, Pages 124-133

  Holbrook, Beth C ^a   Hayward, Sarah L ^a   Blevins, Lance K ^a   Kock, Nancy ^a   Aycock, Tyler ^a   Parks, Griffith D ^a   Alexander Miller, Martha A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody; Bronchus associated lymphoid tissue; Influenza virus; Lung pathology; Neonatal immunity; Respiratory infection

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BRONCHIAL ASSOCIATED LYMPHOID TISSUE; CHLOROCEBUS AETHIOPS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; HIGH RISK INFANT; IMMUNE RESPONSE; INFANT; INFLUENZA; INFLUENZA VIRUS; LUNG INJURY; LYMPHOID TISSUE; NEWBORN; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; UPPER RESPIRATORY TRACT INFECTION; VIRAL CLEARANCE; VIRUS LOAD; ANIMAL; ANTIBODY PRODUCTION; DISEASE MODEL; FEMALE; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS; MALE; NEWBORN DISEASE; PHYSIOLOGY; RESPIRATORY TRACT INFECTION; VIROLOGY;

ANIMALIA; ORTHOMYXOVIRIDAE; PRIMATES;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MALE; RESPIRATORY TRACT INFECTIONS;

EID: 84919776897     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.12.007     Document Type: Article

References (45)

1. Adkins B., Leclerc C., Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 2004, 4:553-564.
2. Bourgeois F.T., Valim C., Wei J.C., McAdam A.J., Mandl K.D. Influenza and other respiratory virus-related emergency department visits among young children. Pediatrics 2006, 118:e1-e8.
3. Bungener L., Geeraedts F., Ter Veer W., Medema J., Wilschut J., Huckriede A. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection. Vaccine 2008, 26:2350-2359.
4. Clements M.L., Betts R.F., Tierney E.L., Murphy B.R. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J. Clin. Microbiol. 1986, 24:157-160.
5. Clerici M., DePalma L., Roilides E., Baker R., Shearer G.M. Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages. J. Clin. Investig. 1993, 91:2829-2836.
6. Eichelberger M., Golding H., Hess M., Weir J., Subbarao K., Luke C.J., Friede M., Wood D. FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US December 10-11, 2007. Vaccine 2008, 26:4299-4303.
7. English B.K., Burchett S.K., English J.D., Ammann A.J., Wara D.W., Wilson C.B. Production of lymphotoxin and tumor necrosis factor by human neonatal mononuclear cells. Pediatr. Res. 1988, 24:717-722.
8. Esposito S., Principi N. The rational use of influenza vaccines in healthy children and children with underlying conditions. Curr. Opin. Infect. Dis. 2009, 22:244-249.
9. Foo S.Y., Phipps S. Regulation of inducible BALT formation and contribution to immunity and pathology. Mucosal Immunol. 2010, 3:537-544.
10. Gans H., DeHovitz R., Forghani B., Beeler J., Maldonado Y., Arvin A.M. Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine 2003, 21:3398-3405.
11. Gerhard W., Mozdzanowska K., Furchner M., Washko G., Maiese K. Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol. Rev. 1997, 159:95-103.
12. GeurtsvanKessel C.H., Willart M.A., Bergen I.M., van Rijt L.S., Muskens F., Elewaut D., Osterhaus A.D., Hendriks R., Rimmelzwaan G.F., Lambrecht B.N. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J. Exp. Med. 2009, 206:2339-2349.
13. Gould S.J., Isaacson P.G. Bronchus-associated lymphoid tissue (BALT) in human fetal and infant lung. J. Pathol. 1993, 169:229-234.
14. Graham M.B., Braciale T.J. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J. Exp. Med. 1997, 186:2063-2068.
15. Groothuis J.R., Levin M.J., Rabalais G.P., Meiklejohn G., Lauer B.A. Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics 1991, 87:823-828.
16. Halasa N.B., Gerber M.A., Chen Q., Wright P.F., Edwards K.M. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants. J. Infect. Dis. 2008, 197:1448-1454.
17. Harris D.T., Schumacher M.J., Locascio J., Besencon F.J., Olson G.B., DeLuca D., Shenker L., Bard J., Boyse E.A. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc. Natl. Acad. Sci. USA 1992, 89:10006-10010.
18. Irvin C.G., Bates J.H. Measuring the lung function in the mouse: the challenge of size. Respir. Res. 2003, 4:4.
19. Ketloy C., Engering A., Srichairatanakul U., Limsalakpetch A., Yongvanitchit K., Pichyangkul S., Ruxrungtham K. Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates. Vet. Immunol. Immunopathol. 2008, 125:18-30.
20. Klimov A., Balish A., Veguilla V., Sun H., Schiffer J., Lu X., Katz J.M., Hancock K. Influenza virus titration, antigenic characterization, and serological methods for antibody detection. Methods Mol. Biol. 2012, 865:25-51.
21. Kocks J.R., Davalos-Misslitz A.C., Hintzen G., Ohl L., Forster R. Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue. J. Exp. Med. 2007, 204:723-734.
22. Laidlaw B.J., Decman V., Ali M.A., Abt M.C., Wolf A.I., Monticelli L.A., Mozdzanowska K., Angelosanto J.M., Artis D., Erikson J., Wherry E.J. Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity. PLoS Pathog. 2013, 9:e1003207.
23. Lee B.O., Rangel-Moreno J., Moyron-Quiroz J.E., Hartson L., Makris M., Sprague F., Lund F.E., Randall T.D. CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection. J. Immunol. 2005, 175:5827-5838.
24. Makori N., Tarantal A.F., Lu F.X., Rourke T., Marthas M.L., McChesney M.B., Hendrickx A.G., Miller C.J. Functional and morphological development of lymphoid tissues and immune regulatory and effector function in rhesus monkeys: cytokine-secreting cells, immunoglobulin-secreting cells, and CD5(+) B-1 cells appear early in fetal development. Clin. Diagn. Lab. Immunol. 2003, 10:140-153.
25. Manicassamy B., Manicassamy S., Belicha-Villanueva A., Pisanelli G., Pulendran B., Garcia-Sastre A. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl. Acad. Sci. USA 2010, 107:11531-11536.
26. McIntosh K., Masters H.B., Orr I., Chao R.K., Barkin R.M. The immunologic response to infection with respiratory syncytial virus in infants. J. Infect. Dis. 1978, 138:24-32.
27. Miscia S., Di Baldassarre A., Sabatino G., Bonvini E., Rana R.A., Vitale M., Di V.V., Manzoli F.A. Inefficient phospholipase C activation and reduced Lck expression characterize the signaling defect of umbilical cord T lymphocytes. J. Immunol. 1999, 163:2416-2424.
28. Moran T.M., Park H., Fernandez-Sesma A., Schulman J.L. Th2 responses to inactivated influenza virus can be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection. J. Infect. Dis. 1999, 180:579-585.
29. Moyron-Quiroz J.E., Rangel-Moreno J., Kusser K., Hartson L., Sprague F., Goodrich S., Woodland D.L., Lund F.E., Randall T.D. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med. 2004, 10:927-934.
30. Naderi N., Pourfathollah A.A., Alimoghaddam K., Moazzeni S.M. Cord blood dendritic cells prevent the differentiation of naive T-helper cells towards Th1 irrespective of their subtype. Clin. Exp. Med. 2009, 9:29-36.
31. Nair H., Simoes E.A., Rudan I., Gessner B.D., Azziz-Baumgartner E., Zhang J.S., Feikin D.R., Mackenzie G.A., Moisi J.C., Roca A., et al. Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet 2013, 381:1380-1390.
32. Norton E.B., Clements J.D., Voss T.G., Cardenas-Freytag L. Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model. J. Virol. 2010, 84:2983-2995.
33. Pabst R., Gehrke I. Is the bronchus-associated lymphoid tissue (BALT) an integral structure of the lung in normal mammals, including humans?. Am. J. Respir. Cell Mol. Biol. 1990, 3:131-135.
34. Pihlgren M., Tougne C., Bozzotti P., Fulurija A., Duchosal M.A., Lambert P.H., Siegrist C.A. Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigens. J. Immunol. 2003, 170:2824-2832.
35. Potter C.W., Oxford J.S. Determinants of immunity to influenza infection in man. Br. Med. Bull. 1979, 35:69-75.
36. Randall T.D. Bronchus-associated lymphoid tissue (BALT) structure and function. Adv. Immunol. 2010, 107:187-241.
37. Randolph D.A. The neonatal adaptive immune system. NeoReviews 2005, 6:e454-e462.
38. Renegar K.B., Small P.A. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J. Virol. 1991, 65:2146-2148.
39. Renegar K.B., Small P.A., Boykins L.G., Wright P.F. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J. Immunol. 2004, 173:1978-1986.
40. Reuman P.D., Ayoub E.M., Small P.A. Influenza infection in the infant mouse. Pediatr. Res. 1983, 17:338-343.
41. Richert L.E., Harmsen A.L., Rynda-Apple A., Wiley J.A., Servid A.E., Douglas T., Harmsen A.G. Inducible bronchus-associated lymphoid tissue (iBALT) synergizes with local lymph nodes during antiviral CD4+ T cell responses. Lymphat. Res. Biol. 2013, 11:196-202.
42. Tregoning J.S., Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin. Microbiol. Rev. 2010, 23:74-98.
43. Tschernig T., Pabst R. Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases. Pathobiology 2000, 68:1-8.
44. Weldon W.C., Wang B.Z., Martin M.P., Koutsonanos D.G., Skountzou I., Compans R.W. Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin. PLoS One 2010, 5:808-e12466.
45. Welliver R.C., Kaul T.N., Putnam T.I., Sun M., Riddlesberger K., Ogra P.L. The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses. J. Pediatr. 1980, 96:808-813.